Business Wire - October 28, 2009
The infectious disease diagnostics market in Zambia presents significant opportunities for manufacturers of low-cost diagnostic products. Infectious diseases, such as HIV/AIDS and Malaria, are receiving heightened attention from donors. However, under-developed laboratory infrastructure is hindering programmes such as anti-retroviral treatment (ART) rollout. Although rapid diagnostic testing (RDT) kits are still relatively new in Zambia, these low-cost products are expected to spur the market for diagnostics and ensure the continued expansion of mass rollout programmes.
"The increased uptake of low-cost RDT kits will drive the infectious disease diagnostics market," notes the analyst of this research. "This, in turn, will create a positive knock-on effect on ART roll-out." Growth in the diagnostics market is expected to be driven by the enhanced availability of low-cost diagnostic kits. Higher levels of donor funding will also promote market expansion.
Laboratory infrastructure in Zambia is under-developed and this, coupled with limited funding, means conventional laboratory tests are not accurate and feasible. Thus, for the market to grow to a significant extent, low-cost alternatives (in the form of RDT kits) would be the viable option. Uptake of these devices in Zambia, however, depends mostly on donor funding, which is expected to continue rising.
Under-developed laboratory infrastructure, lack of skilled personnel and shortage of funding are the most significant restraints to market growth. "Poor infrastructure and lack of skilled personnel leads to inaccurate results and consequently lack of trust from physicians," cautions the analyst. "This lack of trust will severely hinder market growth."
Developing diagnostic products for low income countries, such as RDT kits, that can be utilised at primary care settings and investing in human resource capacity will be critical to gain competitive success.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
* Generic drugs
* Branded pharmaceuticals
* Medical imaging
* Infectious disease diagnostics
This Frost & Sullivan research service titled Strategic Analysis of the Healthcare Industry in Zambia provides an in-depth examination of growth forecasts, competitor analysis and market dynamics. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: generic drugs, branded pharmaceuticals, medical imaging and infectious disease diagnostics.
Key Topics Covered:
* Executive Summary
* Research, Aim and Objectives
* Overview of the Healthcare Industry in Zambia
* Pharmaceuticals Segment
* Medical Devices Segment
* Infectious Disease Diagnostics
* Strategic Recommendations
For more information visit http://www.researchandmarkets.com/research/fc0207/strategic_analysis
Contacts
Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
091028
BW091034
Copyright © 2009 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .